Literature DB >> 8057456

Mutations at palmitylation sites of the influenza virus hemagglutinin affect virus formation.

T Zurcher1, G Luo, P Palese.   

Abstract

The carboxy terminus of the hemagglutinin (HA) of influenza A viruses contains three cysteine residues which are highly conserved among HA subtypes. It has previously been shown for the H2, H3, and H7 subtypes of HA that these cysteine residues are modified by the covalent attachment of palmitic acid. In order to study the role of the acylated cysteines in the formation of infectious influenza viruses, we introduced mutations into the HA of influenza A/WSN/33 virus (H1 subtype) by reverse-genetics techniques. We found that the cysteine at position 563 of the cytoplasmic tail is required for infectious-particle formation. The cysteine at position 560 can be changed to alanine or tyrosine to yield virus strains that are attenuated in cell cultures. The change from cysteine at position 553 to serine or alanine does not significantly alter the phenotype of the virus. The requirement for a cysteine at position 563 suggests a functional role for palmitylation of the cytoplasmic tail. This interpretation is further supported by experiments in which two or more of the cysteine residues were mutated, eliminating potential palmitylation sites. None of these double or triple mutations resulted in infectious virus. Selection of revertants of the attenuated cysteine-to-tyrosine mutant (mutation at position 560) always resulted in reversion to cysteine rather than to other amino acids. Although our data indicate a biological role for the conserved cysteine residues in the cytoplasmic tail of the HA of influenza viruses, we cannot exclude the possibility that structural constraints in the cytoplasmic tail of the HA--rather than altered palmitylation--are the determining factors for infectious-particle formation.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8057456      PMCID: PMC236978     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  29 in total

1.  Molecular characterization of a new hemagglutinin, subtype H14, of influenza A virus.

Authors:  Y Kawaoka; S Yamnikova; T M Chambers; D K Lvov; R G Webster
Journal:  Virology       Date:  1990-12       Impact factor: 3.616

2.  Mx protein: constitutive expression in 3T3 cells transformed with cloned Mx cDNA confers selective resistance to influenza virus.

Authors:  P Staeheli; O Haller; W Boll; J Lindenmann; C Weissmann
Journal:  Cell       Date:  1986-01-17       Impact factor: 41.582

Review 3.  Structure of the influenza virus hemagglutinin.

Authors:  C W Ward
Journal:  Curr Top Microbiol Immunol       Date:  1981       Impact factor: 4.291

4.  Complete sequence analysis shows that the hemagglutinins of the H0 and H2 subtypes of human influenza virus are closely related.

Authors:  A L Hiti; A R Davis; D P Nayak
Journal:  Virology       Date:  1981-05       Impact factor: 3.616

5.  Palmitoylation of the influenza A virus M2 protein.

Authors:  R J Sugrue; R B Belshe; A J Hay
Journal:  Virology       Date:  1990-11       Impact factor: 3.616

6.  Transformation of mammalian cells with an amplifiable dominant-acting gene.

Authors:  M Wigler; M Perucho; D Kurtz; S Dana; A Pellicer; R Axel; S Silverstein
Journal:  Proc Natl Acad Sci U S A       Date:  1980-06       Impact factor: 11.205

7.  Cerulenin blocks fatty acid acylation of glycoproteins and inhibits vesicular stomatitis and Sindbis virus particle formation.

Authors:  M J Schlesinger; C Malfer
Journal:  J Biol Chem       Date:  1982-09-10       Impact factor: 5.157

8.  Virulence factors of influenza A viruses: WSN virus neuraminidase required for plaque production in MDBK cells.

Authors:  J L Schulman; P Palese
Journal:  J Virol       Date:  1977-10       Impact factor: 5.103

9.  On the structure of the acyl linkage and the function of fatty acyl chains in the influenza virus haemagglutinin and the glycoproteins of Semliki Forest virus.

Authors:  M F Schmidt; B Lambrecht
Journal:  J Gen Virol       Date:  1985-12       Impact factor: 3.891

10.  Mutations in the cytoplasmic domain of the influenza virus hemagglutinin affect different stages of intracellular transport.

Authors:  C Doyle; M G Roth; J Sambrook; M J Gething
Journal:  J Cell Biol       Date:  1985-03       Impact factor: 10.539

View more
  32 in total

1.  The carboxy-terminal domain of glycoprotein N of human cytomegalovirus is required for virion morphogenesis.

Authors:  Michael Mach; Karolina Osinski; Barbara Kropff; Ursula Schloetzer-Schrehardt; Magdalena Krzyzaniak; William Britt
Journal:  J Virol       Date:  2007-01-17       Impact factor: 5.103

2.  Palmitoylations on murine coronavirus spike proteins are essential for virion assembly and infectivity.

Authors:  Edward B Thorp; Joseph A Boscarino; Hillary L Logan; Jeffrey T Goletz; Thomas M Gallagher
Journal:  J Virol       Date:  2006-02       Impact factor: 5.103

3.  Reverse genetics system for generation of an influenza A virus mutant containing a deletion of the carboxyl-terminal residue of M2 protein.

Authors:  M R Castrucci; Y Kawaoka
Journal:  J Virol       Date:  1995-05       Impact factor: 5.103

4.  Elongation of the cytoplasmic tail interferes with the fusion activity of influenza virus hemagglutinin.

Authors:  M Ohuchi; C Fischer; R Ohuchi; A Herwig; H D Klenk
Journal:  J Virol       Date:  1998-05       Impact factor: 5.103

5.  Palmitylation of the influenza virus hemagglutinin (H3) is not essential for virus assembly or infectivity.

Authors:  H Jin; K Subbarao; S Bagai; G P Leser; B R Murphy; R A Lamb
Journal:  J Virol       Date:  1996-03       Impact factor: 5.103

6.  Ebola virus glycoprotein: proteolytic processing, acylation, cell tropism, and detection of neutralizing antibodies.

Authors:  H Ito; S Watanabe; A Takada; Y Kawaoka
Journal:  J Virol       Date:  2001-02       Impact factor: 5.103

7.  Adaptive mutations in Sindbis virus E2 and Ross River virus E1 that allow efficient budding of chimeric viruses.

Authors:  K H Kim; E G Strauss; J H Strauss
Journal:  J Virol       Date:  2000-03       Impact factor: 5.103

8.  Apical budding of a recombinant influenza A virus expressing a hemagglutinin protein with a basolateral localization signal.

Authors:  Rosalia Mora; Enrique Rodriguez-Boulan; Peter Palese; Adolfo García-Sastre
Journal:  J Virol       Date:  2002-04       Impact factor: 5.103

9.  Human immunodeficiency virus type 1 envelope glycoproteins that lack cytoplasmic domain cysteines: impact on association with membrane lipid rafts and incorporation onto budding virus particles.

Authors:  Jayanta Bhattacharya; Paul J Peters; Paul R Clapham
Journal:  J Virol       Date:  2004-05       Impact factor: 5.103

10.  Evidence that Gag facilitates HIV-1 envelope association both in GPI-enriched plasma membrane and detergent resistant membranes and facilitates envelope incorporation onto virions in primary CD4+ T cells.

Authors:  Ajit Patil; Archana Gautam; Jayanta Bhattacharya
Journal:  Virol J       Date:  2010-01-08       Impact factor: 4.099

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.